Antimycobacterial therapy in Crohn's disease: game over?
Peyrin-Biroulet
Laurent
L
Neut
Christel
C
Colombel
Jean-Frédéric
JF
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy* / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D009164:Mycobacterium Infections / Q000150:complications*; D009162:Mycobacterium avium / Q000145:classification*; D017828:Rifabutin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D017828:Rifabutin; D002991:Clofazimine; D017291:Clarithromycin